[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ihara et al., 1989 - Google Patents

Natural Killing of Varicella‐Zoster Virus (VZV)‐Infected Fibroblasts in Normal Children, Children with VZV Infections, and Children with Hodgkin's Disease

Ihara et al., 1989

Document ID
4317876864161074966
Author
Ihara T
Kamiya H
Starr S
Arbeter A
Lange B
Publication year
Publication venue
Pediatrics International

External Links

Snippet

We studied mononuclear cell (MNC)—mediated natural killing (NK) of varicella‐zoster virus (VZV)—infected fibroblasts in normal children, children with VZV infections, and children with Hodgkin's disease. NK activity was tested in 18hr 51Cr release assays. NK activity for …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
Thorley-Lawson The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
Levin et al. Evaluation of the human interferon system in viral disease.
Sullivan et al. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
Ching et al. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody
Fleisher et al. A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections
Arvin et al. Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants
Roberts Jr et al. Virus-induced interferon production by human macrophages
Starr et al. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers
Herrod et al. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies
Bazarbachi et al. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives
Tosato et al. T cell-mediated immunoregulation of Epstein Barr virus-(EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Forthal et al. Degree and length of viremia in adults with measles
IE862265L (en) Inhibiting aids virus in vitro
Sullivan et al. Treatment of life-threatening Epstein-Barr virus infections with acyclovir
Diehl et al. Effect of a herpes group virus (EBV) on growth of peripheral leukocyte cultures
Streicher et al. In vitro inhibition of human herpesvirus-6 by phosphonoformate
Szelc et al. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection
Sanchez-Lanier et al. Measles virus-induced suppression of lymphocyte proliferation
IL91415A (en) Anti-viral compositions comprising compounds of adenosine or salts or a metabolite thereof
Bandyopadhyay et al. Natural killer cell‐mediated lysis of T cell lines chronically infected with HIV‐1
Ihara et al. Natural Killing of Varicella‐Zoster Virus (VZV)‐Infected Fibroblasts in Normal Children, Children with VZV Infections, and Children with Hodgkin's Disease
Gratama et al. Detection of multiple Epstein‐Barr viral strains in allogeneic bone marrow transplant recipients
Galama et al. Measles virus inhibits acquisition of lymphocyte functions but not established effector functions
Miguelez et al. Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir
Rickinson et al. Mechanism of the establishment of epstein‐barr virus genome‐containing lymphoid cell lines from infectious mononucleosis patients: Studies with phosphonoacetate